Patient Guide: A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 38 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07215559
Status: NOT_YET_RECRUITING
Condition: Obesity, Overweight, Diabetes Mellitus, Type 2
Phase: PHASE2

Where You Can Participate

This study is available at 38 locations across the country.

Top locations include:
  • • Gilbert, Arizona
  • • Phoenix, Arizona
  • • Tucson, Arizona
  • • And 35 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes - Join Clinical Trial NCTNCT07215559

How to Join This Clinical Trial - NCTNCT07215559

Learn how to participate in this PHASE2 trial studying an investigational therapy for Obesity, Overweight, Diabetes Mellitus, Type 2. Current status: NOT_YET_RECRUITING.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Obesity, Overweight, Diabetes Mellitus, Type 2. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Obesity, Overweight, Diabetes Mellitus, Type 2
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
NOT_YET_RECRUITING
Study Identifier
NCTNCT07215559 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 38 locations. Find a study site near you:

Clinical Research Site

Gilbert, Arizona 85296 - United States

Status: Contact for availability

Clinical Research Site

Phoenix, Arizona 85020 - United States

Status: Contact for availability

Clinical Research Site

Tucson, Arizona 85741 - United States

Status: Contact for availability

Clinical Research Site

Atlanta, Georgia 30331 - United States

Status: Contact for availability

Clinical Research Site

Lawrenceville, Georgia 30043 - United States

Status: Contact for availability

Clinical Research Site

Sandy Springs, Georgia 30328 - United States

Status: Contact for availability

Clinical Research Site

Stonecrest, Georgia 30038 - United States

Status: Contact for availability

Clinical Research Site

Union City, Georgia 30291 - United States

Status: Contact for availability

Clinical Research Site

Las Vegas, Nevada 89128 - United States

Status: Contact for availability

Clinical Research Site

Trenton, New Jersey 08611 - United States

Status: Contact for availability

And 28 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Obesity, Overweight, Diabetes Mellitus, Type 2:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships